Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guy Pratt

Showing results (21-30 of 134) with videos related to

Pageof 14
Sort By:
Genes, Chromosomes & Cancer|December 30, 2003
Translocation t(11;14) in multiple myeloma: Analysis of translocation breakpoints on der(11) and der(14) chromosomes suggests complex molecular mechanisms of recombinationJames A L Fenton, Guy Pratt, Dominic G Rothwell, et al.
Leukemia Research|February 7, 2006
Two germ line polymorphisms of the tumour suppressor gene p53 may influence the biology of chronic lymphocytic leukaemiaGeothy Kochethu, Julio Delgado, Chris Pepper, et al.
British Journal of Haematology|July 6, 2017
Guidelines for the use of imaging in the management of patients with myelomaAndrew Chantry, Majid Kazmi, Sally Barrington, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2005
Common polymorphism G(-248)A in the promoter region of the bax gene results in significantly shorter survival in patients with chronic lymphocytic Leukemia once treatment is initiatedJane Starczynski, Chris Pepper, Guy Pratt, et al.
Blood|March 19, 2014
Development and characterization of a physiologically relevant model of lymphocyte migration in chronic lymphocytic leukemiaElisabeth Walsby, Andrea Buggins, Stephen Devereux, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|September 19, 2018
Successful Renal Outcome in Membranoproliferative Glomerulonephritis Following Treatment of the Underlying Subtle Clone: A Case ReportRitika Rana, Paul Cockwell, Bindu Vydianath, et al.
Frontiers in Oncology|March 13, 2023
Benefits of switching from intravenous to subcutaneous daratumumab: Perspectives from UK healthcare providersGordon Cook, John Ashcroft, Mariana Fernandez, et al.
Transplantation Proceedings|March 8, 2020
Post-transplant Monoclonal Gammopathy of Renal Significance: A Case SeriesRitika Rana, Paul Cockwell, Guy Pratt, et al.
British Journal of Haematology|October 3, 2012
The genotype of RAET1L (ULBP6), a ligand for human NKG2D (KLRK1), markedly influences the clinical outcome of allogeneic stem cell transplantationAyman Antoun, Dhruti Vekaria, Rafik A Salama, et al.
Molecular Cancer Therapeutics|June 3, 2010
The NF-kappaB inhibitor LC-1 has single agent activity in multiple myeloma cells and synergizes with bortezomibElisabeth J Walsby, Guy Pratt, Saman Hewamana, et al.
Pageof 14

Showing results (21-30 of 134) with videos related to

Sort By:
Pageof 14
Genes, Chromosomes & Cancer|December 30, 2003
Translocation t(11;14) in multiple myeloma: Analysis of translocation breakpoints on der(11) and der(14) chromosomes suggests complex molecular mechanisms of recombinationJames A L Fenton, Guy Pratt, Dominic G Rothwell, et al.
Leukemia Research|February 7, 2006
Two germ line polymorphisms of the tumour suppressor gene p53 may influence the biology of chronic lymphocytic leukaemiaGeothy Kochethu, Julio Delgado, Chris Pepper, et al.
British Journal of Haematology|July 6, 2017
Guidelines for the use of imaging in the management of patients with myelomaAndrew Chantry, Majid Kazmi, Sally Barrington, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2005
Common polymorphism G(-248)A in the promoter region of the bax gene results in significantly shorter survival in patients with chronic lymphocytic Leukemia once treatment is initiatedJane Starczynski, Chris Pepper, Guy Pratt, et al.
Blood|March 19, 2014
Development and characterization of a physiologically relevant model of lymphocyte migration in chronic lymphocytic leukemiaElisabeth Walsby, Andrea Buggins, Stephen Devereux, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|September 19, 2018
Successful Renal Outcome in Membranoproliferative Glomerulonephritis Following Treatment of the Underlying Subtle Clone: A Case ReportRitika Rana, Paul Cockwell, Bindu Vydianath, et al.
Frontiers in Oncology|March 13, 2023
Benefits of switching from intravenous to subcutaneous daratumumab: Perspectives from UK healthcare providersGordon Cook, John Ashcroft, Mariana Fernandez, et al.
Transplantation Proceedings|March 8, 2020
Post-transplant Monoclonal Gammopathy of Renal Significance: A Case SeriesRitika Rana, Paul Cockwell, Guy Pratt, et al.
British Journal of Haematology|October 3, 2012
The genotype of RAET1L (ULBP6), a ligand for human NKG2D (KLRK1), markedly influences the clinical outcome of allogeneic stem cell transplantationAyman Antoun, Dhruti Vekaria, Rafik A Salama, et al.
Molecular Cancer Therapeutics|June 3, 2010
The NF-kappaB inhibitor LC-1 has single agent activity in multiple myeloma cells and synergizes with bortezomibElisabeth J Walsby, Guy Pratt, Saman Hewamana, et al.
Pageof 14